Exploring the limits in low rectal cancer

Affiliations

Comment

Brendan Moran. Lancet Oncol. 2012 Jun.

. 2012 Jun;13(6):565-7.

doi: 10.1016/S1470-2045(12)70177-8. Epub 2012 May 15.

¹ Colorectal Research Unit, North Hampshire Hospital, Basingstoke, Hampshire RG24 9NA, UK. brendan.moran@hhft.nhs.uk

No abstract available

Comment on

Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
Fujita S, Akasu T, Mizusawa J, Saito N, Kinugasa Y, Kanemitsu Y, Ohue M, Fujii S, Shiozawa M, Yamaguchi T, Moriya Y; Colorectal Cancer Study Group of Japan Clinical Oncology Group. Fujita S, et al. Lancet Oncol. 2012 Jun;13(6):616-21. doi: 10.1016/S1470-2045(12)70158-4. Epub 2012 May 15. Lancet Oncol. 2012. PMID: 22591948 Clinical Trial.